Artículos Novel coronavirus 2019-nCoV prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV COVID-19 Cuadro Clínico Epidemiología Ver recurso
Artículos Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19 COVID-19 Virología y Patogenia Laboratorio +1 Ver recurso
Artículos New onset acute symptomatic seizure and risk factors in coronavirus disease 2019 COVID-19 Complicaciones Ver recurso
Artículos Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19 COVID-19 Cuadro Clínico Ver recurso
Artículos Detection of SARS-CoV-2 in Different Types of Clinical Specimens COVID-19 Laboratorio PCR Ver recurso
Artículos Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19 COVID-19 Tratamientos Ver recurso
Artículos Prone Position and Lung Ventilation:Perfusion Matching in Acute Respiratory Failure Due to COVID-19 COVID-19 Ver recurso
Artículos Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 COVID-19 Tratamientos Ver recurso
Artículos Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network COVID-19 Subgrupos Grupos de Riesgo +1 Ver recurso
Artículos Angiotensin-converting enzyme 2 coated nanoparticles containing respiratory masks, chewing gums and nasal filters may be used for protection COVID-19 Medidas Preventivas Ver recurso
Artículos Quantifying additional COVID-19 symptoms will save lives COVID-19 Cuadro Clínico Ver recurso
Artículos Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City- a prospective cohort study COVID-19 Cuadro Clínico Subgrupos +2 Ver recurso
Artículos Physical interventions to interrupt or reduce the spread of respiratory viruses (Review) COVID-19 Medidas Preventivas Ver recurso
Artículos An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic COVID-19 Subgrupos Grupos de Riesgo +1 Ver recurso
